Correction: Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: a comprehensive literature review of a rare retinal vasculopathy - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: A Comprehensive Literature Review of Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) Syndrome, a Rare Retinal Vasculopathy

  • By

  • Haidara Asaad

  • Raghad Hasan

  • October 7, 2026

Share

Clinical Scorecard: Correction: A Comprehensive Literature Review of Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) Syndrome, a Rare Retinal Vasculopathy

At a Glance

CategoryDetail
ConditionIdiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome
Key MechanismsNot described in the correction notice.
Target PopulationNot specified in the correction notice.
Care SettingOphthalmology; the notice concerns attribution of a figure in a literature review about IRVAN syndrome.

Key Highlights

  • The notice corrects the original article after the Figure 2 legend was found to omit its attribution.
  • The revised legend acknowledges reproduction of an excerpt from Medical Hypotheses, volume 111, pages 12–14.
  • The excerpt is from a 2018 article by Chawla and colleagues concerning multimodal imaging and IRVAN syndrome etiology.
  • The excerpt was reproduced with Elsevier’s permission.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          No patient population or prescribing information is provided in the correction notice.

          No treatment information is provided in the correction notice.

          Clinical Best Practices

          • The correction states that the Figure 2 legend was revised to include the omitted attribution.

          Related Resources & Content

          Original Source(s)

          Related Content